The ranking of the 15 best-selling prescription drugs in the world in 2010 was drawn up by Bloomberg magazine, highlighting the turnover for each medicine and the difference compared to 2009. The turnover for Lipitor is equal to 10.7 billion dollars, but the largest increase in sales was the Crestor.
|
14 FEB Here is the ranking of the 15 best-selling prescription medicines in the world. It was compiled by the financial magazine Bloomberg, which highlighted both the 2010 worldwide turnover (for billions of dollars) and the difference with respect to 2009. 1. lipitor (Pfizer) turnover 10.7 billion euros (deviation -6%) 2. Plavix (Bristol-Myers/ Sanofi-Aventis) revenue $9.43 billion (deviation -4%) 3. Remicade (J&J/Merck & Co.) turnover of 7.99 billion dollars (offset not available) 4. Advair (Glaxo Smith Kline) turnover of 7.94 billion dollars (deviation +2%) 5. Enbrel (Amgen/Pfizer/Takeda) revenue $7.23 billion (offset not available) 6. Enable (Bristol-Myers/Otsuka) turnover of 6.78 billion dollars (offset not available) 7. Humira (Abbott) revenue $6.55 billion (deviation 19%) 8. Avastin (Roche) revenue $6.22 billion (deviation +8%) 9. Rituxan/ Mabthera (Roche/Biogen Idec) revenue $6.11 billion (deviation +9%) 10. Diovan (Novartis) revenue $6.05 billion (deviation +1%) 
|
